Diabetes Pharmacology

Diabetes Pharmacology

The purpose of this course is to meet the needs of nursing professionals seeking a better understanding of the actions, dosages, onset of action, and adverse effects of diabetes medications in order to provide optimal care to their patient population. In addition, members of the public may use this course to enhance their personal knowledge […]

U.S. Army Medical Correspondence Course: Therapeutics I - Pharmacy, Anatomy, Pharmacology, Anesthetic, Central Nervous System, Surgery, Sedative, Anticonvulsant, Narcotics, CNS Stimulants

U.S. Army Medical Correspondence Course: Therapeutics I – Pharmacy, Anatomy, Pharmacology, Anesthetic, Central Nervous System, Surgery, Sedative, Anticonvulsant, Narcotics, CNS Stimulants

A patient who visits a physician or physician extender frequently receives a prescription for a medication. That prescription is brought to the pharmacy to be filled. The patient expects professional attention at the pharmacy. Part of that expectation involves any caution or warning the patient should heed while taking the medication. In your role, you […]

Darbepoetin Alfa (Aranesp) (Pharmacology Notes) (Drug Overview)

Darbepoetin Alfa (Aranesp) (Pharmacology Notes) (Drug Overview)

The Food and Drug Administration (FDA) approved darbepoetin alfa (Aranesp) for treatment of anemia as sociated with chronic renal failure (CRF) in patients on dialysis and patients not on dialysis (1). The manufacturer of the drug also filed an application with the FDA on September 18, 2001, to receive an indication for treatment of anemia […]

Postoperative Glycemic Control in Cardiac Surgery Patients (Pharmacology Notes) (Report)

Postoperative Glycemic Control in Cardiac Surgery Patients (Pharmacology Notes) (Report)

Blood glucose management in critically ill patients remains an ongoing controversy. In recent years, clinical trials evaluating blood glucose control in critically ill patients advocated for intense blood glucose management, with target blood glucose levels between 80 and 110 mg/dL (1). Intense blood glucose control resulted in a reduction in morbidity and mortality in the […]

Eszopiclone (Lunesta): A New Nonbenzodiazepine Hypnotic Agent (Pharmacology Notes) (Drug Overview)

Eszopiclone (Lunesta): A New Nonbenzodiazepine Hypnotic Agent (Pharmacology Notes) (Drug Overview)

Randomized, placebo-controlled trials have shown that eszopiclone, a newly available nonbenzodiazepine hypnotic, effectively treats the symptoms of insomnia. Its pharmacokinetic and pharmacodynamic parameters are similar to those of the other currently available nonbenzodiazepine hypnotics (i.e., zolpidem and zaleplon). The unique quality of eszopiclone lies in its product labeling. It is not restricted to short-term use, […]